Cargando…

Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer

BACKGROUND: Early detection of colorectal cancer (CRC) is essential to reduce cancer-related morbidity and mortality. Stool DNA (sDNA) testing is an emerging method for early CRC detection. Syndecan-2 (SDC2) methylation is a potential biomarker for the sDNA testing. Aberrant DNA methylation is an ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ji Hyeong, Oh, Tae Jeong, An, Sungwhan, Lee, Kyung Ha, Kim, Ji Yeon, Kim, Jin Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600770/
https://www.ncbi.nlm.nih.gov/pubmed/37901726
http://dx.doi.org/10.4240/wjgs.v15.i9.2032
_version_ 1785126058316529664
author Song, Ji Hyeong
Oh, Tae Jeong
An, Sungwhan
Lee, Kyung Ha
Kim, Ji Yeon
Kim, Jin Soo
author_facet Song, Ji Hyeong
Oh, Tae Jeong
An, Sungwhan
Lee, Kyung Ha
Kim, Ji Yeon
Kim, Jin Soo
author_sort Song, Ji Hyeong
collection PubMed
description BACKGROUND: Early detection of colorectal cancer (CRC) is essential to reduce cancer-related morbidity and mortality. Stool DNA (sDNA) testing is an emerging method for early CRC detection. Syndecan-2 (SDC2) methylation is a potential biomarker for the sDNA testing. Aberrant DNA methylation is an early epigenetic event during tumorigenesis and can occur in the normal colonic mucosa during aging, which can compromise the sDNA test results. AIM: To determine whether methylated SDC2 in sDNA normalizes after surgical resection of CRC. METHODS: In this prospective study, we enrolled 151 patients with CRC who underwent curative surgical resection between September 2016 and May 2020. Preoperative stool samples were collected from 123 patients and postoperative samples were collected from 122 patients. A total of 104 samples were collected from both preoperative and postoperative patients. Aberrant promoter methylation of SDC2 in sDNA was assessed using linear target enrichment quantitative methylation-specific real-time polymerase chain reaction. Clinicopathological parameters were analyzed using the results of SDC2 methylation. RESULTS: Detection rates of SDC2 methylation in the preoperative and postoperative stool samples were 88.6% and 19.7%, respectively. Large tumor size (3 cm, P = 0.019) and advanced T stage (T3–T4, P = 0.033) were positively associated with the detection rate of SDC2 methylation before surgery. Female sex was associated with false positives after surgery (P = 0.030). Cycle threshold (C(T)) values were significantly decreased postoperatively compared with preoperative values (P < 0.001). The postoperative negative conversion rate for preoperatively methylated SDC2 was 79.3% (73/92). CONCLUSION: Our results suggested that the SDC2 methylation test for sDNA has acceptable sensitivity and specificity. However, small size and early T stage tumors are associated with a low detection rate of SDC2 methylation. As the cycle threshold values significantly decreased after surgery, SDC2 methylation test for sDNA might have a diagnostic value for CRC.
format Online
Article
Text
id pubmed-10600770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-106007702023-10-27 Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer Song, Ji Hyeong Oh, Tae Jeong An, Sungwhan Lee, Kyung Ha Kim, Ji Yeon Kim, Jin Soo World J Gastrointest Surg Observational Study BACKGROUND: Early detection of colorectal cancer (CRC) is essential to reduce cancer-related morbidity and mortality. Stool DNA (sDNA) testing is an emerging method for early CRC detection. Syndecan-2 (SDC2) methylation is a potential biomarker for the sDNA testing. Aberrant DNA methylation is an early epigenetic event during tumorigenesis and can occur in the normal colonic mucosa during aging, which can compromise the sDNA test results. AIM: To determine whether methylated SDC2 in sDNA normalizes after surgical resection of CRC. METHODS: In this prospective study, we enrolled 151 patients with CRC who underwent curative surgical resection between September 2016 and May 2020. Preoperative stool samples were collected from 123 patients and postoperative samples were collected from 122 patients. A total of 104 samples were collected from both preoperative and postoperative patients. Aberrant promoter methylation of SDC2 in sDNA was assessed using linear target enrichment quantitative methylation-specific real-time polymerase chain reaction. Clinicopathological parameters were analyzed using the results of SDC2 methylation. RESULTS: Detection rates of SDC2 methylation in the preoperative and postoperative stool samples were 88.6% and 19.7%, respectively. Large tumor size (3 cm, P = 0.019) and advanced T stage (T3–T4, P = 0.033) were positively associated with the detection rate of SDC2 methylation before surgery. Female sex was associated with false positives after surgery (P = 0.030). Cycle threshold (C(T)) values were significantly decreased postoperatively compared with preoperative values (P < 0.001). The postoperative negative conversion rate for preoperatively methylated SDC2 was 79.3% (73/92). CONCLUSION: Our results suggested that the SDC2 methylation test for sDNA has acceptable sensitivity and specificity. However, small size and early T stage tumors are associated with a low detection rate of SDC2 methylation. As the cycle threshold values significantly decreased after surgery, SDC2 methylation test for sDNA might have a diagnostic value for CRC. Baishideng Publishing Group Inc 2023-09-27 2023-09-27 /pmc/articles/PMC10600770/ /pubmed/37901726 http://dx.doi.org/10.4240/wjgs.v15.i9.2032 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Observational Study
Song, Ji Hyeong
Oh, Tae Jeong
An, Sungwhan
Lee, Kyung Ha
Kim, Ji Yeon
Kim, Jin Soo
Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
title Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
title_full Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
title_fullStr Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
title_full_unstemmed Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
title_short Comparative detection of syndecan-2 methylation in preoperative and postoperative stool DNA in patients with colorectal cancer
title_sort comparative detection of syndecan-2 methylation in preoperative and postoperative stool dna in patients with colorectal cancer
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600770/
https://www.ncbi.nlm.nih.gov/pubmed/37901726
http://dx.doi.org/10.4240/wjgs.v15.i9.2032
work_keys_str_mv AT songjihyeong comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer
AT ohtaejeong comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer
AT ansungwhan comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer
AT leekyungha comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer
AT kimjiyeon comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer
AT kimjinsoo comparativedetectionofsyndecan2methylationinpreoperativeandpostoperativestooldnainpatientswithcolorectalcancer